Substituted cycloalkyl P1' hepatitis C virus inhibitors
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
-
Page/Page column 132
(2010/02/06)
HETEROCYCLICSULFONAMIDE HEPATITIS C VIRUS INHIBITORS
The present invention relates to tripeptide compounds, compositionscontaining such compounds and methods for using such compounds for the treatment of heptitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositionscontaining such analogs and methods for using these analogs in the treatment of HCV infection.
-
Page 87
(2010/02/05)
More Articles about upstream products of 445306-48-9